Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator
一项随机、安慰剂对照、双盲 II 期试验，比较单次标准剂量与高剂量 CVD 103-HgR 减毒活口服霍乱疫苗的反应原性和免疫原性，并以 Shanchol 灭活口服疫苗作为开放标签免疫学对照。
期刊:Clinical and Vaccine Immunology
影响因子:
doi:10.1128/CVI.00265-17
Sow, Samba O; Tapia, Milagritos D; Chen, Wilbur H; Haidara, Fadima C; Kotloff, Karen L; Pasetti, Marcela F; Blackwelder, William C; Traoré, Awa; Tamboura, Boubou; Doumbia, Moussa; Diallo, Fatoumata; Coulibaly, Flanon; Onwuchekwa, Uma; Kodio, Mamoudou; Tennant, Sharon M; Reymann, Mardi; Lam, Diana F; Gurwith, Marc; Lock, Michael; Yonker, Thomas; Smith, Jonathan; Simon, Jakub K; Levine, Myron M
